Education
About Us
Working with TipRanks
Follow Us
iShares U.S. Pharmaceuticals ETF (IHE)
NYSEARCA:IHE
IHE Stock Chart & Stats
Day’s Range― - ―
52-Week Range$62.68 - $73.11
Previous Close$65.5
Volume90.56K
Average Volume (3M)64.24K
Market Cap
$602.79M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.57
Next EarningsN/A
EPS EstimateN/A
Last Dividend Ex-Date
Dec 17, 2024Dividend Yield1.56%
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume63,623
30 Day Avg. Volume64,242
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$87.45Price Target Upside33.23% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering309
---
iShares U.S. Pharmaceuticals ETF News
---
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
-0.94% Mutual Funds
40.95% Other Institutional Investors
59.99% Public Companies and
Individual Investors
IHE FAQ
What was iShares U.S. Pharmaceuticals ETF’s price range in the past 12 months?
iShares U.S. Pharmaceuticals ETF lowest stock price was $62.67 and its highest was $73.11 in the past 12 months.
What is iShares U.S. Pharmaceuticals ETF’s market cap?
iShares U.S. Pharmaceuticals ETF’s market cap is $602.79M.
When is iShares U.S. Pharmaceuticals ETF’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were iShares U.S. Pharmaceuticals ETF’s earnings last quarter?
Currently, no data Available
Is iShares U.S. Pharmaceuticals ETF overvalued?
According to Wall Street analysts iShares U.S. Pharmaceuticals ETF’s price is currently Undervalued.
Does iShares U.S. Pharmaceuticals ETF pay dividends?
iShares U.S. Pharmaceuticals ETF pays a Quarterly dividend of $0.21 which represents an annual dividend yield of 1.56%. See more information on iShares U.S. Pharmaceuticals ETF dividends here
What is iShares U.S. Pharmaceuticals ETF’s EPS estimate?
iShares U.S. Pharmaceuticals ETF’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does iShares U.S. Pharmaceuticals ETF have?
Currently, no data Available
What happened to iShares U.S. Pharmaceuticals ETF’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of iShares U.S. Pharmaceuticals ETF?
Currently, no hedge funds are holding shares in IHE
---
iShares U.S. Pharmaceuticals ETF Stock Smart Score
Technical Analysis
---